Active clinical trials
We have a number of clinical trials, across a range of diseases
All of them are designed to help us refine our test so that we can ultimately help patients and doctors make better treatment choices.
Many of them have been highlighted by charities such as Kidney Cancer UK and Breast Cancer Now
Early triple negative breast cancer: PEAR-TNBC (UK, Open)
Metastatic triple negative breast cancer: PEAR-MET (UK Open, US 2024)
Early kidney cancer: PEAR-TREE (UK, Open)
Metastatic kidney cancer: PEAR-TREE2 (UK 2023, US 2024)
Early liver cancer (UK)